Abstract
Infection with Neisseria gonorrhoeae can trigger an intense inflammatory response, yet there is little specific immune response or development of immune memory. In addition, gonorrhea typically correlates with a transient reduction in T lymphocyte counts in blood, and these populations recover when gonococcal infection is resolved. Such observations suggest that the gonococci have a suppressive effect on the host immune response. We report here that N. gonorrhoeae Opa proteins were able to bind CEACAM1 expressed by primary CD4+ T lymphocytes and suppress their activation and proliferation. CEACAM1 bound by gonococcal Opa52 associated with the tyrosine phosphatases SHP-1 and SHP-2, which implicates the receptor's ITIM (immunoreceptor tyrosine-based inhibitory motif) in this effect.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Handsfield, H. H. Neisseria gonorrhoeae in Principles and Practice of Infectious Diseases edn 3 (eds. J. E. Bennet, R. G. Douglas and G. L. Mandell) 1613–1631 (Churchill Livingstone, New York, 1990).
Al-Suleiman, S. A., Grimes, E. M. & Jonas, H. S. Disseminated gonococcal infections. Obstet. Gynecol. 61, 48–51 (1983).
Nassif, X., Pujol, C., Morand, P. & Eugene, E. Interactions of pathogenic Neisseria with host cells. Is it possible to assemble the puzzle? Mol. Microbiol. 32, 1124–1132 (1999).
Plummer, F. A. et al. Antibodies to opacity proteins (Opa) correlate with a reduced risk of gonococcal salpingitis. J. Clin. Invest. 93, 1748–1755 (1994).
Fox, K. K. et al. Longitudinal evaluation of serovar-specific immunity to Neisseria gonorrhoeae. Am. J. Epidemiol. 149, 353–358 (1999).
Hobbs, M. M. et al. Molecular typing of Neisseria gonorrhoeae causing repeated infections: evolution of porin during passage within a community. J. Infect. Dis. 179, 371–381 (1999).
Hedges, S. R., Sibley, D. A., Mayo, M. S., Hook, E. W. & Russell, M. W. Cytokine and antibody responses in women infected with Neisseria gonorrhoeae : effects of concomitant infections. J. Infect. Dis. 178, 742–751 (1998).
Hedges, S. R., Mayo, M. S., Mestecky, J., Hook, E. W. & Russell, M. W. Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections. Infect. Immun. 67, 3937–3946 (1999).
Kozlowski, P. A., Cu-Uvin, S., Neutra, M. R. & Flanigan, T. P. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect. Immun. 65, 1387–1394 (1997).
Anzala, A. O. et al. Acute sexually transmitted infections increase human immunodeficiency virus type 1 plasma viremia, increase plasma type 2 cytokines, and decrease CD4 cell counts. J. Infect. Dis. 182, 459–466 (2000).
Hillis, S. D., Nakashima, A., Marchbanks, P. A., Addiss, D. G. & Davis, J. P. Risk factors for recurrent Chlamydia trachomatis infections in women. Am. J. Obstet. Gynecol. 170, 801–806 (1994).
Cohen, M. S. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet 351, 5–7 (1998).
Fleming, D. T. & Wasserheit, J. N. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex. Transm. Infect. 75, 3–17 (1999).
Dehio, C., Gray-Owen, S. D. & Meyer T. F. The role of neisserial Opa proteins in interactions with host cells. Trends Microbiol. 6, 489–495 (1998).
Swanson, J., Barrera, O., Sola, J. & Boslego, J. Expression of outer membrane protein II by gonococci in experimental gonorrhea. J. Exp. Med. 168, 2121–2130 (1988).
Jerse, A. E. et al. Multiple gonococcal opacity proteins are expressed during experimental urethral infection in the male. J. Exp. Med. 179, 911–920 (1994).
Schmidt, K. A., Deal, C. D., Kwan, M., Thattassery, E. & Schneider, H. Neisseria gonorrhoeae MS11mkC opacity protein expression in vitro and during human volunteer infectivity studies. Sex. Transm. Dis. 27, 278–283 (2000).
Lammel, C. J. et al. Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae. J. Infect. Dis. 152, 990–1001 (1985).
Gray-Owen, S. D., Lorenzen, D. R., Haude, A., Meyer, T. F. & Dehio, C. Differential Opa specificities for CD66 receptors influence tissue interactions and cellular response to Neisseria gonorrhoeae. Mol. Microbiol. 26, 971–980 (1997).
Virji, M., Watt, S., Barker, K., Makepeace, K. & Doyonnas, R. The N-domain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae. Mol. Microbiol. 22, 929–939 (1996).
Thompson, J. A., Grunert, F. & Zimmermann, W. Carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J. Clin. Lab. Anal. 5, 344–366 (1991).
Beauchemin, N. et al. Redefined nomenclature for members of the carcinoembryonic antigen family. Exp. Cell Res. 252, 243–249 (1999).
Taylor, L. S., Paul, S. P. & McVicar, D. W. Paired inhibitory and activating receptor signals. Rev. Immunogenet. 2, 204–219 (2000).
Christensen, M. D. & Geisler, C. Recruitment of SHP-1 protein tyrosine phosphatase and signalling by a chimeric T-cell receptor-killer inhibitory receptor. Scand. J. Immunol. 51, 557–564 (2000).
Pluskota, E., Chen, Y. & D'Souza, S. E. Src homology domain 2-containing tyrosine phosphatase 2 associates with intercellular adhesion molecule 1 to regulate cell survival. J. Biol. Chem. 275, 30029–30036 (2000).
Muraille, E., Bruhns, P., Pesesse, X., Daeron, M. & Erneux, C. The SH2 domain containing inositol 5-phosphatase SHIP2 associates to the immunoreceptor tyrosine-based inhibition motif of FcγRIIB in B cells under negative signaling. Immunol. Lett. 72, 7–15 (2000).
Beauchemin, N. et al. Association of biliary glycoprotein with protein tyrosine phosphatase SHP-1 in malignant colon epithelial cells. Oncogene 14, 783–790 (1997).
Huber, M. et al. The carboxyl-terminal region of biliary glycoprotein controls its tyrosine phosphorylation and association with protein-tyrosine phosphatases SHP-1 and SHP-2 in epithelial cells. J. Biol. Chem. 274, 335–344 (1999).
Brummer, J., Neumaier, M., Gopfert, C. & Wagener, C. Association of pp60c-src with biliary glycoprotein (CD66a), an adhesion molecule of the carcinoembryonic antigen family downregulated in colorectal carcinomas. Oncogene 11, 1649–1655 (1995).
Izzi, L., Turbide, C., Houde, C., Kunath, T. & Beauchemin, N. cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function. Oncogene 18, 5563–5572 (1999).
Kammerer, R., Hahn, S., Singer, B. B., Luo, J. S. & von Kleist, S. Biliary glycoprotein (CD66a), a cell adhesion molecule of the immunoglobulin superfamily, on human lymphocytes: structure, expression and involvement in T cell activation. Eur. J. Immunol. 28, 3664–3674 (1998).
Donda, A. et al. Locally inducible CD66a (CEACAM1) as an amplifier of the human intestinal T cell response. Eur. J. Immunol. 30, 2593–2603 (2000).
Morales, V. M. et al. Regulation of human intestinal intraepithelial lymphocyte cytolytic function by biliary glycoprotein (CD66a). J. Immunol. 163, 1363–1370 (1999).
Mardiney, M., Brown, M. R. & Fleisher, T. A. Measurement of T-cell CD69 expression: a rapid and efficient means to assess mitogen- or antigen-induced proliferative capacity in normals. Cytometry 26, 305–310 (1996).
Vilanova, M. et al. Role of monocytes in the up-regulation of the early activation marker CD69 on B and T murine lymphocytes induced by microbial mitogens. Scand. J. Immunol. 43, 155–163 (1996).
Chen, W. et al. Co-ligation of CD31 and Fcγ RII induces cytokine production in human monocytes. J. Immunol. 152, 3991–3997 (1994).
Janssen, O. et al. Differential regulation of activation-induced cell death in individual human T cell clones. Int. Arch. Allergy Immunol. 121, 183–193 (2000).
Cella, M. et al. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing. J. Exp. Med. 185, 1743–1751 (1997).
Carretero, M. et al. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants. Eur. J. Immunol. 28, 1280–1291 (1998).
Meyaard, L. et al. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 7, 283–290 (1997).
Chen, T. et al. Biliary glycoprotein (BGPa, CD66a, CEACAM1) mediates inhibitory signals. J. Leukoc. Biol. 70, 335–340 (2001).
Hauck, C. R., Meyer, T. F., Lang, F. & Gulbins, E. CD66-mediated phagocytosis of Opa52 Neisseria gonorrhoeae requires a Src-like tyrosine kinase- and Rac1-dependent signalling pathway. EMBO J. 17, 443–454 (1998).
Dennehy, K. M. et al. Thymocyte activation induces the association of phosphatidylinositol 3-kinase and pp120 with CD5. Eur. J. Immunol. 27, 679–686 (1997).
Janssen, O., Sanzenbacher, R. & Kabelitz, D. Regulation of activation-induced cell death of mature T-lymphocyte populations. Cell. Tiss. Res. 301, 85–99 (2000).
Kamal, M., Katira, A. & Gordon, J. Stimulation of B lymphocytes via CD72 (human Lyb-2). Eur. J. Immunol. 21, 1419–1424 (1991).
Lozano, F. et al. CD5 signal transduction: positive or negative modulation of antigen receptor signaling. Crit. Rev. Immunol. 20, 347–358 (2000).
Perez-Villar, J. J. et al. CD5 negatively regulates the T cell antigen receptor signal transduction pathway: Involvement of SH2-containing phosphotyrosine phosphatase SHP-1. Mol. Cell. Biol. 19, 2903–2912 (1999).
Piali, L. et al. Murine platelet endothelial cell adhesion molecule (PECAM-1)/CD31 modulates β2 integrins on lymphokine-activated killer cells. Eur. J. Immunol. 23, 2464–2471 (1993).
Newton-Nash, D. K. & Newman, P. J. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): Inhibition of TCR-mediated signal transduction. J. Immunol. 163, 682–688 (1999).
Adachi, T., Wakabayashi, C., Nakayama, T., Yakura, H. & Tsubata, T. CD72 negatively regulates signaling through the antigen receptor of B cells. J. Immunol. 164, 1223–1229 (2000).
Levine, W. C. et al. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J. Infect. Dis. 177, 167–174 (1998).
McGee, Z. A., Johnson, A. P. & Taylor-Robinson, D. Pathogenic mechanisms of Neisseria gonorrhoeae : observations on damage to human fallopian tubes in organ culture by gonococci of colony type 1 or type 4. J. Infect. Dis. 143, 413–422 (1981).
Clynes, R. et al. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory receptors. J. Exp. Med. 189, 179–185 (1999).
Jerse, A. E. Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice. Infect. Immun. 67, 5699–5708 (1999).
Cohen, M. S. & Cannon, J. G. Human experimentation with Neisseria gonorrhoeae : progress and goals. J. Infect. Dis. 179, 375–379 (1999).
Virji, M., Makepeace, K., Ferguson, D. J. P. & Watt, S. Carcinoembryonic antigens (CD66) on epithelial cells and neutrophils are receptors for Opa proteins of pathogenic neisseriae. Mol. Microbiol. 22, 941–950 (1996).
Hill, D. J. et al. The variable P5 proteins of typeable and nontypeable Haemophilus influenzae target human CEACAM1. Mol. Microbiol. 39, 850–862 (2001).
Kupsch, E.-M., Knepper, B., Kuroki, T., Heuer, I. & Meyer, T. F. Variable opacity (Opa) outer membrane proteins account for the cell tropisms displayed by Neisseria gonorrhoeae for human leukocytes and epithelial cells. EMBO J. 12, 641–650 (1993).
Achtman, M. et al. Purification and characterization of eight class 5 outer membrane protein variants from a clone of Neisseria meningitidis serogroup A. J. Exp. Med. 168, 507–525 (1988).
Dillard, J. P. & Seifert HS. A peptidoglycan hydrolase similar to bacteriophage endolysins acts as an autolysin in Neisseria gonorrhoeae. Mol. Microbiol. 25, 893–901 (1997).
Acknowledgements
We thank E. M. Bertram, J. Cannons, A. Cochrane, H. Ginzberg, K. Ireton, M. Luscher, E. Liao, S. E. McCaw, K. McDonald, M. Ostrowski and T. Watts for critical comments on and/or technical assistance. Supported by the Canadian Institutes for Health Research Operating Grant # MT-15499.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
C. B. and S. D. G.-O. have filed a US provisional patent application entitled “Ligation of CEACAM1”, which describes the ability of CEACAM1 ligation to modulate immune cell responses and the potential applications of this effect.
Rights and permissions
About this article
Cite this article
Boulton, I., Gray-Owen, S. Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes. Nat Immunol 3, 229–236 (2002). https://doi.org/10.1038/ni769
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni769
This article is cited by
-
Human CEACAM1 is targeted by a Streptococcus pyogenes adhesin implicated in puerperal sepsis pathogenesis
Nature Communications (2023)
-
Alternative splicing after gene duplication drives CEACAM1-paralog diversification in the horse
BMC Evolutionary Biology (2018)
-
Coevolution of paired receptors in Xenopus carcinoembryonic antigen-related cell adhesion molecule families suggests appropriation as pathogen receptors
BMC Genomics (2016)
-
The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis
Histochemistry and Cell Biology (2016)
-
Exome sequencing identifies a novel CEACAM16 mutation associated with autosomal dominant nonsyndromic hearing loss DFNA4B in a Chinese family
Journal of Human Genetics (2015)